370 related articles for article (PubMed ID: 10554808)
1. Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology. Scandinavian MDS Group, Sweden and Norway.
Hellström-Lindberg E; Kanter-Lewensohn L; Nichol J; Ost A
Br J Haematol; 1999 Jun; 105(4):966-73. PubMed ID: 10554808
[TBL] [Abstract][Full Text] [Related]
2. Colony-forming unit-megakaryocyte (CFR-meg) numbers and serum thrombopoietin concentrations in thrombocytopenic disorders: an inverse correlation in myelodysplastic syndromes.
Wang W; Matsuo T; Yoshida S; Mori H; Miyazaki Y; Kuriyama K; Tomonaga M
Leukemia; 2000 Oct; 14(10):1751-6. PubMed ID: 11021750
[TBL] [Abstract][Full Text] [Related]
3. Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.
Tamura H; Ogata K; Luo S; Nakamura K; Yokose N; Dan K; Tohyama K; Yoshida Y; Hamaguchi H; Sakamaki H; Kuwaki T; Tahara T; Kato T; Nomura T
Br J Haematol; 1998 Dec; 103(3):778-84. PubMed ID: 9858230
[TBL] [Abstract][Full Text] [Related]
4. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.
Hou M; Andersson PO; Stockelberg D; Mellqvist UH; Ridell B; Wadenvik H
Br J Haematol; 1998 Jun; 101(3):420-4. PubMed ID: 9633881
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin and myelodysplastic syndromes.
Ogata K; Tamura H
Int J Hematol; 2000 Aug; 72(2):173-7. PubMed ID: 11039665
[TBL] [Abstract][Full Text] [Related]
6. Endogenous serum thrombopoietin concentrations in patients with myelodysplastic syndromes.
Zwierzina H; Rollinger-Holzinger I; Nuessler V; Herold M; Meng YG
Leukemia; 1998 Jan; 12(1):59-64. PubMed ID: 9436921
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
8. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes.
Luo SS; Ogata K; Yokose N; Kato T; Dan K
Stem Cells; 2000; 18(2):112-9. PubMed ID: 10742383
[TBL] [Abstract][Full Text] [Related]
9. Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
Mantovani L; Lentini G; Hentschel B; Wickramanayake PD; Loeffler M; Diehl V; Tesch H
Br J Haematol; 2000 May; 109(2):367-75. PubMed ID: 10848827
[TBL] [Abstract][Full Text] [Related]
10. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin level in young patients is related to megakaryocyte frequency and platelet count.
Kuefer MU; Wang WC; Head DR; Wilimas JA; Furman WL; Liu Q; Hornkohl AC; Best DM; Jackson CW
J Pediatr Hematol Oncol; 1998; 20(1):36-43. PubMed ID: 9482411
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
Kasper C; Zahner J; Sayer HG
J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome.
Hsu HC; Lee YM; Tsai WH; Jiang ML; Ho CH; Ho CK; Wang SY
Oncology; 2002; 63(1):64-9. PubMed ID: 12187073
[TBL] [Abstract][Full Text] [Related]
14. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies.
Watts TL; Murray NA; Roberts IA
Pediatr Res; 1999 Jul; 46(1):28-32. PubMed ID: 10400130
[TBL] [Abstract][Full Text] [Related]
16. Measurement of serum cytokine levels in patients with myelodysplastic syndromes.
Verhoef GE; De Schouwer P; Ceuppens JL; Van Damme J; Goossens W; Boogaerts MA
Leukemia; 1992 Dec; 6(12):1268-72. PubMed ID: 1280751
[TBL] [Abstract][Full Text] [Related]
17. Revisiting use of growth factors in myelodysplastic syndromes.
Newman K; Maness-Harris L; El-Hemaidi I; Akhtari M
Asian Pac J Cancer Prev; 2012; 13(4):1081-91. PubMed ID: 22799286
[TBL] [Abstract][Full Text] [Related]
18. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels.
Ando M; Iwamoto Y; Suda A; Tsuchiya K; Nihei H
Blood; 2001 Feb; 97(4):915-21. PubMed ID: 11159517
[TBL] [Abstract][Full Text] [Related]
19. Circulating thrombopoietin levels in neonates with infection.
Colarizi P; Fiorucci P; Caradonna A; Ficuccilli F; Mancuso M; Papoff P
Acta Paediatr; 1999 Mar; 88(3):332-7. PubMed ID: 10229048
[TBL] [Abstract][Full Text] [Related]
20. Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia.
Shinjo K; Takeshita A; Nakamura S; Naitoh K; Yanagi M; Tobita T; Ohnishi K; Ohno R
Leukemia; 1998 Mar; 12(3):295-300. PubMed ID: 9529122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
